Company news

PMGC Holdings Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD

July 29, 2024

Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line

June 27, 2024

Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024

June 25, 2024

Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs

June 13, 2024

Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm

May 28, 2024

Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference

May 21, 2024

Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries

May 16, 2024

Elevai Labs Inc. Reports First Quarter 2024 Financial Results

May 14, 2024

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity

May 1, 2024

Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare

April 30, 2024

Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments

April 30, 2024

Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments

April 28, 2024

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

March 28, 2024

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

January 23, 2024

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

January 16, 2024

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

January 15, 2024

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences

January 1, 2024

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023

December 10, 2023

ELEVAI Labs, Inc. Expands International Distribution into Europe

December 6, 2023

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products

November 28, 2023

ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering

November 23, 2023

← Newer news releases

Decks